CN Patent

CN1311670A — 胆碱能试剂在治疗老花眼中的应用

Assigned to Allergan Inc · Expires 2001-09-05 · 25y expired

What this patent protects

公开了增加或减少副交感/胆碱能/睫状体紧张性收缩以恢复眼睛的静止位置并允许正常的正性调节和负性调节的方法,所述方法包括,向老花眼患者施用有效量的毒蕈硷药物。

USPTO Abstract

公开了增加或减少副交感/胆碱能/睫状体紧张性收缩以恢复眼睛的静止位置并允许正常的正性调节和负性调节的方法,所述方法包括,向老花眼患者施用有效量的毒蕈硷药物。

Drugs covered by this patent

pilocarpine-hydrochloride (PILOCARPINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1311670A
Jurisdiction: CN
Classification: —
Expires: 2001-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.